Market Pulse
Daily · Sep 17, 2026 · data.go.kr + ECOS
KOSPI
6,715.41
-2.56 (-0.04%)
KOSDAQ
822.18
+6.20 (+0.76%)
KOSPI 200
1,058.27
-1.78 (-0.17%)
USD/KRW
1,382.20
237690KOSDAQ·Oct 30, 2025
Above-consensus results led by oligo CDMO revenue
Mirae Asset Securities published a company analysis report on ST PHARM CO., LTD. (237690) titled "Above-consensus results led by oligo CDMO revenue".
Summary
Covers ST PHARM CO., LTD. (237690).
Covered stock
More on 237690
2Q26 review: Unexpected one-off factorMirae Asset Securities · Jul 29, 2026Initiating Coverage: RNA Era: On the Precipice of Full-on GrowthKB Securities · May 27, 2026Earnings seasonality to ease from 2026Mirae Asset Securities · Feb 10, 20262Q25 results beat consensusMirae Asset Securities · Jul 28, 2025Meaningful order intake neededMirae Asset Securities · Jan 24, 2025